SUCHARD; Suzanne J.

Patent Applications and Registrations

Patent applications and USPTO patent grants for SUCHARD; Suzanne J..The latest application filed is for "antagonistic cd40 monoclonal antibodies and uses thereof".

Company Profile

6.18.21

SUCHARD; Suzanne J. - Portland OR
Suchard; Suzanne J. - Wilmington DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof App 20220177596 - YAMNIUK; Aaron ; et al.	2022-06-09
Methods Of Treating Systemic Lupus Erythematosus Using A Domain Antibody Directed Against Cd28 App 20220144951 - Valencia; Xavier ; et al.	2022-05-12
Antibody Polypeptides That Antagonize Cd40l App 20220073636 - NADLER; Steven G. ; et al.	2022-03-10
Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28 Grant 11,267,888 - Valencia , et al. March 8, 2	2022-03-08
Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activity Grant 11,220,550 - Yamniuk , et al. January 11, 2	2022-01-11
Antibody polypeptides that antagonize CD40L Grant 11,180,567 - Nadler , et al. November 23, 2	2021-11-23
Predictive Peripheral Blood Biomarker For Checkpoint Inhibitors App 20210123920 - MANJARREZ ORDUNO; Nataly ; et al.	2021-04-29
Compositions Monovalent For Cd28 Binding And Methods Of Use App 20210047414 - McKinnon; Murray ; et al.	2021-02-18
Compositions monovalent for CD28 binding and methods of use Grant 10,919,965 - McKinnon , et al. February 16, 2	2021-02-16
Methods Of Treating Systemic Lupus Erythematosus Using A Domain Antibody Directed Against Cd28 App 20200247890 - Kind Code	2020-08-06
MODIFIED IgG1 Fc DOMAINS AND ANTI-CD40 DOMAIN ANTIBODY FUSIONS THEREWITH App 20200148779 - YAMNIUK; Aaron ; et al.	2020-05-14
Method of using antibody polypeptides that antagonize CD40 to treat IBD Grant 10,435,475 - Honczarenko , et al. O	2019-10-08
Antibody Polypeptides That Antagonize Cd40l App 20190100595 - NADLER; Steven G. ; et al.	2019-04-04
Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L Grant 10,196,451 - Nadler , et al. Fe	2019-02-05
Antagonistic Cd40 Monoclonal Antibodies And Uses Thereof App 20180340031 - Yamniuk; Aaron ; et al.	2018-11-29
Compositions Monovalent For Cd28 Binding And Methods Of Use App 20180142023 - McKinnon; Murray ; et al.	2018-05-24
Compositions monovalent for CD28 binding and methods of use Grant 9,908,937 - McKinnon , et al. March 6, 2	2018-03-06
Antibody Polypeptides That Antagonize Cd40l App 20180051091 - NADLER; Steven G. ; et al.	2018-02-22
Antibody polypeptides that antagonize CD40L Grant 9,765,150 - Nadler , et al. September 19, 2	2017-09-19
Method Of Using Antibody Polypeptides That Antagonize Cd40 To Treat Ibd App 20160355596 - HONCZARENKO; Marek ; et al.	2016-12-08
Antibody Polypeptides That Antagonize Cd40l App 20160075790 - NADLER; Steven G. ; et al.	2016-03-17
Antibody polypeptides that antagonize CD40L Grant 9,228,018 - Nadler , et al. January 5, 2	2016-01-05
Compositions Monovalent For Cd28 Binding And Methods Of Use App 20150299321 - McKinnon; Murray ; et al.	2015-10-22
Compositions monovalent for CD28 binding and methods of use Grant 9,085,629 - McKinnon , et al. July 21, 2	2015-07-21
Nucleic acids encoding antibody polypeptides that antagonize CD40L Grant 8,981,072 - Nadler , et al. March 17, 2	2015-03-17
Antibody Polypeptides That Antagonize Cd40l App 20150023976 - NADLER; Steven G. ; et al.	2015-01-22
Antibody polypeptides that antagonize CD40L Grant 8,895,010 - Nadler , et al. November 25, 2	2014-11-25
Antibody Polypeptides That Antagonize Cd40l App 20140099707 - NADLER; Steven G. ; et al.	2014-04-10
Compositions monovalent for CD28 binding and methods of use Grant 8,454,959 - McKinnon , et al. June 4, 2	2013-06-04
Compositions Monovalent For Cd28 Binding And Methods Of Use App 20130109846 - McKinnon; Murray ; et al.	2013-05-02
Antibody Polypeptides That Antagonize Cd40l App 20130095109 - NADLER; Steven G. ; et al.	2013-04-18
Compositions Monovalent For Cd28 Binding And Methods Of Use App 20120201814 - McKinnon; Murray ; et al.	2012-08-09
Compositions monovalent for CD28 binding and methods of use Grant 8,168,759 - McKinnon , et al. May 1, 2	2012-05-01
Compositions Monovalent For Cd28 Binding And Methods Of Use App 20100028354 - McKinnon; Murray ; et al.	2010-02-04
Human phosphatase RET31, and variants thereof Grant 7,358,074 - Jackson , et al. April 15, 2	2008-04-15
Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof Grant 7,153,678 - Jackson , et al. December 26, 2	2006-12-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.